However, relatively little has been reported in highly fatal liver cancers, but there are still reports of APOBEC3B upregulation in liver cancer patients, contradicting the restriction of HBV infection and liver cancer by APOBEC3B via degrading the HBV genome (69, 71). Here, APOBEC3B is linked to liver cancer.